tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Sakar Healthcare Ltd Confirms Compliance with SEBI Regulations for Q2 2025

Story Highlights
  • Sakar Healthcare Ltd submitted a SEBI compliance certificate for Q2 2025.
  • The company confirmed dematerialization and listing of securities, ensuring regulatory compliance.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Sakar Healthcare Ltd Confirms Compliance with SEBI Regulations for Q2 2025

Elevate Your Investing Strategy:

Sakar Healthcare Ltd ( (IN:SAKAR) ) has shared an update.

Sakar Healthcare Ltd has submitted a confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending June 30, 2025. This announcement confirms the dematerialization of securities and their listing on stock exchanges, ensuring compliance with regulatory requirements and maintaining transparency for stakeholders.

More about Sakar Healthcare Ltd

Sakar Healthcare Ltd operates in the healthcare industry, focusing on the production and distribution of pharmaceutical products. The company is involved in the manufacturing of a wide range of healthcare solutions, catering to various medical needs and contributing to the pharmaceutical sector.

Average Trading Volume: 38,887

Current Market Cap: 7.69B INR

For detailed information about SAKAR stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1